Current Assets Alterar Data
AbbVie USD 33.22B 4.37B 2023-09
Abbott USD 23.51B 872M 2023-06
ALKERMES USD 1.46B 67.43M 2023-09
Amgen USD 30.33B 18.14B 2023-12
AstraZeneca USD 22.5B 338M 2023-09
Biogen USD 6.86B 1.59B 2023-12
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Catalent USD 2.57B 44M 2023-12
Eli Lilly USD 23.01B 1.68B 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
GlaxoSmithKline GBP 21.24B 1.89B 2023-09
J&J USD 53.7B 6.86B 2023-09
Merck USD 31.95B 1.98B 2023-09
Perrigo USD 2.77B 7.7M 2023-09
Pfizer USD 74.01B 665M 2023-09
Phibro Animal Health USD 584.42M 1.3M 2023-09
Prestige Brands USD 393.79M 5.59M 2023-12
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Revance Therapeutics USD 388.52M 9.57M 2023-09
Roche Holding CHF 30.98B 2.84B 2023-06
United Therapeutics USD 3.55B 92.1M 2023-12
Zoetis USD 6.34B 121M 2023-12



Bristol-Myers Squibb Ativo Circulante - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Mar 2024.